New genetic test to detect cancer in healthy people
Pathway's screening represents a first in 'liquid biopsy' testing
Chicago
PATHWAY Genomics, a company known for pushing the boundaries of direct-to-consumer genetic testing, was to launch on Thursday a cancer screening test designed to detect bits of cancer DNA in the blood of otherwise healthy people.
The test represents a first in the rapidly developing field of "liquid biopsies", which use gene sequencing technology to screen blood samples to trace amounts of DNA associated with different cancers.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Technology
Brokers’ take: DBS cuts Venture Corp price target after Q1 earnings miss
Garmin’s Q1 results beat on strong demand for fitness, auto products
Foxconn’s musical chairs sound like punk rock
US sets up board to advise on safe, secure use of AI
Regulate AI? How US, EU and China are going about It
Meta’s results are best viewed through rose-tinted AI glasses